This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Invokana
  • /
  • Canagliflozin-Mealtime Insulin Rescue
Clinical trial

Canagliflozin-Mealtime Insulin Rescue

Read time: 1 mins
Last updated:1st Jan 2016

24-week, randomized, double blind, placebo-controlled trial to evaluate safety and efficacy of canagliflozin as compared with placebo in reducing the need for mealtime insulin in subjects with type 2 diabetes currently using a basal-bolus insulin regimen.

Study Type: Interventional
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Treatment
Official Title: Canagliflozin-Mealtime Insulin Rescue
Estimated Enrollment: 40
Study Start Date: January 2016
Estimated Study Completion Date: November 2018
Estimated Primary Completion Date: November 2018 (Final data collection date for primary outcome measure)

- Active Comparator:
- Placebo Comparator: placebo

Category Value
Study start date 2016-01-01

View full details